Deinove announced it has been granted six new patents in the United States. These patents include:
- “Process for chromosomal engineering using a novel DNA repair system”, Deinove’s founding patent, is already registered in Europe. It describes the mechanism behind the biodiversity and resistance of Deinococcus bacteria, a major discovery made by Prof. Miroslav Radman’s team, which led to the launch of Deinove.
- “Methods for isolating bacteria” protects a method for selecting and identifying bacteria that has enabled the company to build a strain library with over 6,000 bacterial strains, all resistant to UV radiation.
- “Use of bacteria for the production of bio-energy”, already issued in Europe, Eurasia and Australia, protects the production of biofuel from lignocellulosic biomass by using Deinococcus bacteria.
- “Compositions and methods for degrading lignocellulosic biomass”, already issued in China, extends the previous patent to other bacteria related to Deinococci and which are present in the Deinove strain library.
- “Recombinant bacteria and the use of thereof for producing ethanol” protects Deinococci that have undergone genomic modifications in view of bioethanol production.
- “Laccases and uses of thereof” protects enzymes involved in degrading lignin, namely Deinococcus laccases, as well as their use in degrading or modifying biomass.
The patents were issued following the “High-performance metabolic bacteria” patent issued at the end of 2014, which deals with the method of biofuel production from cellulosic or hemicellulosic raw materials using an integrated process for degradation and fermentation based on Deinococcus bacteria.
Deinove now holds a portfolio of 170 patents internationally, divided into 19 families, representing a strategic asset for signing partnerships. With these patents, Deinove is pursuing a strategy of protecting its intellectual property, notably in the key market of the United States.